Novo Deepens Denmark Commitment With $1.2B Rare Disease Production Facility

Retrieved on: 2024-12-16 19:32:27

Tags for this article:

Click the tags to see associated articles and topics

Novo Deepens Denmark Commitment With $1.2B Rare Disease Production Facility. View article details on hiswai:

Excerpt

Novo's latest investment comes just days after the U.S. FTC greenlit the highly contentious acquisition of Catalent, which analysts expect will ...

Article found on: www.biospace.com